Under construction – not a live service
Sign in
Not yet taking people in ItalyNo phase

Personalized music during heart artery procedures for people with acute coronary syndrome

Tests personalized music for easing anxiety in adults having coronary artery procedures.

Plain-language title generated from the registry record
Registry title: Music Medicine in Coronary Interventional Cardiology Procedures

Key facts

Where
Sassari, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07786961, who can take part

Where in Italy

  • SS Annunziata Hospital, SassariSassari, ItalyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Azienda Ospedaliero Universitaria di Sassari
Trial code
NCT07786961
Record updated
26 August 2026
Original description
The purpose of the study is: to evaluate the effectiveness of a personalized Music Medicine intervention in patients undergoing invasive coronary interventional cardiology procedures. The study will compare patients who listen to a personalized music playlist through wireless earphones throughout the procedure with patients receiving standard care without music. The primary objective is to assess whether Music Medicine reduces state anxiety, measured using the State-Trait Anxiety Inventory (STAI-Y1). Secondary objectives are to evaluate its effects on access-site crossover, procedural pain, blood pressure, heart rate, and oxygen saturation. The study will also assess adverse reactions, withdrawals, patient satisfaction with the intervention, and, in the Music Medicine group, patients' perceived experience through a semi-structured qualitative interview. The study is designed as a prospective, single-center, open-label, randomized controlled trial with two parallel groups and a 1:1 allocation ratio, enrolling 208 participants.Read full original descriptionShow less

Effects of Music Medicine in Patients Undergoing Coronary Interventional Cardiology Procedures

The purpose of the study is: to evaluate the effectiveness of a personalized Music Medicine intervention in patients undergoing invasive coronary interventional cardiology procedures. The study will compare patients who listen to a personalized music playlist through wireless earphones throughout the procedure with patients receiving standard care without music. The primary objective is to assess whether Music Medicine reduces state anxiety, measured using the State-Trait Anxiety Inventory (STAI-Y1). Secondary objectives are to evaluate its effects on access-site crossover, procedural pain, blood pressure, heart rate, and oxygen saturation. The study will also assess adverse reactions, withdrawals, patient satisfaction with the intervention, and, in the Music Medicine group, patients' perceived experience through a semi-structured qualitative interview. The study is designed as a prospective, single-center, open-label, randomized controlled trial with two parallel groups and a 1:1 allocation ratio, enrolling 208 participants.

The question the study is trying to answer is: whether listening to a personalized music playlist during an invasive coronary interventional cardiology procedure, in addition to standard care, reduces state anxiety compared with standard care alone, and whether it also improves other relevant procedural outcomes, including pain, the need for access-site crossover, blood pressure, heart rate, and oxygen saturation, without interfering with routine clinical care

Inclusion: age >18 years; provision of written informed consent and ability to understand the informed consent form.

Exclusion: use of antipsychotic medications, assessed through clinical history; patients with ST-segment elevation myocardial infarction (STEMI); patients with very-high-risk non-ST-segment elevation myocardial infarction (NSTEMI), as classified according to the 2023 European Society of Cardiology (ESC) Guidelines; presence of hearing impairment or deafness, assessed through clinical history; patients with resuscitated cardiac arrest; history of epilepsy, assessed through clinical history; patients in cardiogenic shock; patients unable to express their musical preferences.

ClinicalTrials.gov NCT07786961